STLtoday - Business - Story: "'This has a credibility cost. Merck's brand and stature are tarnished by this,' said David Moskowitz, an analyst at Friedman, Billings, Ramsey. "
. . .
Some doctors had complaints about Merck, saying the company tried to squelch negative opinions on Vioxx's safety and play down the drug's risks. [St. Louis Today]
